ConductScience.org, home

Paper6836645

Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery.

Auer LM and 2 others. Stroke, 1983. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery. Papers, record 6836645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6836645

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery.
PubMed
Journal
Stroke
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
4.48
iCite
Revised in PubMed
2019-07-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Auer LML M
2Oberbauer RWR W
3Schalk HVH V

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
Cerebral RevascularizationMajor topic
Nicotinic AcidsMajor topic
VasodilationMajor topic
Adult
Aged
Female
Humans
Infusions, Parenteral
Male
Middle Aged
Nimodipine
Pia Mater

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
34367053Cerebral Autoregulation in Subarachnoid Hemorrhage.Front Neurol2021https://conductscience.org/library/papers/34367053PubMed
31662526Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.In Vivo2019https://conductscience.org/library/papers/31662526PubMed
6650240Acute surgery of cerebral aneurysms and prevention of symptomatic vasospasm.Acta Neurochir (Wien)1983https://conductscience.org/library/papers/6650240PubMed
3974174[Effect of the Ca antagonist nimodipine on global and regional cerebrovascular circulation].Klin Wochenschr1985https://conductscience.org/library/papers/3974174PubMed
3751707Nimodipine and early aneurysm operation in good condition SAH patients.Acta Neurochir (Wien)1986https://conductscience.org/library/papers/3751707PubMed
3538789Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.Acta Neurochir (Wien)1986https://conductscience.org/library/papers/3538789PubMed
3333430Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine.Neurosurg Rev1987https://conductscience.org/library/papers/3333430PubMed
3329302Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage.Neurosurg Rev1987https://conductscience.org/library/papers/3329302PubMed
3146212Intraoperative use of laser Doppler in the study of cerebral microvascular circulation.Acta Neurochir (Wien)1988https://conductscience.org/library/papers/3146212PubMed
3104433Influence of nimodipine and nifedipine on intrapulmonary shunting--a comparison to other vasoactive drugs.Intensive Care Med1987https://conductscience.org/library/papers/3104433PubMed
2955675Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.Acta Neurochir (Wien)1987https://conductscience.org/library/papers/2955675PubMed
2663415Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.Drugs1989https://conductscience.org/library/papers/2663415PubMed
1504442Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.Drugs Aging1992https://conductscience.org/library/papers/1504442PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6836645

GET https://conductscience.org/api/papers/v1/6836645/authors